IMPACT Therapeutics

IMPACT Therapeutics

IMPACT Therapeutics is a China based Company. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$691m (Public information from Apr 2024)
Nanjing Jiangsu (HQ)
  • Edit

Recent News about IMPACT Therapeutics

Edit
More about IMPACT Therapeuticsinfo icon
Edit

Impact Therapeutics is a biopharmaceutical company focused on developing innovative cancer therapies. The company operates in the oncology market, targeting both patients and healthcare providers. Its business model revolves around the discovery and clinical translation of novel drugs designed to treat various forms of cancer. By integrating drug discovery with clinical trials, Impact Therapeutics aims to bring effective treatments to market more efficiently. The company generates revenue through partnerships, licensing agreements, and the commercialization of its proprietary drugs. Key clients include hospitals, cancer treatment centers, and pharmaceutical companies. Impact Therapeutics leverages its expertise in personalized cancer therapy to improve patient outcomes and advance the field of oncology.

Keywords: cancer therapy, drug discovery, clinical trials, oncology, biopharmaceutical, personalized medicine, healthcare, innovation, patient outcomes, partnerships.